BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Lupin Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500257
ISIN Demat
INE326A01037
Book Value (Rs)
595.6712081
NSE Symbol
LUPIN
Divident Yield %
0.51
Market Cap
(Rs In Cr.)
106,601
P/E (TTM)
19.28
EPS (TTM)
120.99
Face Value
(Rs)
2
Back
Lupin consolidated net profit rises 37.47% in the December 2025 quarter
13-Feb-26   Hrs IST

Net profit of Lupin rose 37.47% to Rs 1175.55 crore in the quarter ended December 2025 as against Rs 855.16 crore during the previous quarter ended December 2024. Sales rose 26.37% to Rs 7100.45 crore in the quarter ended December 2025 as against Rs 5618.56 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales7100.455618.56 26
OPM %31.8624.13 -
PBDT2261.571342.72 68
PBT1948.611071.27 82
NP1175.55855.16 37

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)